| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 04/18/2007 | CN1311077C Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives |
| 04/18/2007 | CN1310948C Modified peptides as therapeutic agents |
| 04/18/2007 | CN1310947C Gamma-1 and gamma-3 anti-human CD23 monoclonal antibodies and use as the rapentics |
| 04/18/2007 | CN1310921C Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/18/2007 | CN1310906C Indole-type derivatives as inhibitors of p38 kinase |
| 04/18/2007 | CN1310900C Bi-aromatic compounds and pharmaceutical and cosmetic compositions containing the same |
| 04/18/2007 | CN1310885C Benzenesulfonate of 4-fluoro-2-cyanopyrrolidine derivative |
| 04/18/2007 | CN1310679C Method of achieving persistent transgene expression |
| 04/18/2007 | CN1310678C Administration of agents for the treatment of inflammation |
| 04/18/2007 | CN1310676C Method for improving immune response |
| 04/18/2007 | CN1310674C Medicinal composition for treating serious acute respiratory syndrome |
| 04/18/2007 | CN1310673C Composition of multiple scattered mixture contg.polypeptide and its pharm compsn. |
| 04/18/2007 | CN1310672C Osteogenis oligopeptide as blood-formation stimulation articles |
| 04/18/2007 | CN1310652C Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells |
| 04/18/2007 | CN1310642C Methods and compositions to enhance white blood cell count |
| 04/18/2007 | CN1310640C Pharmaceutical compositions |
| 04/17/2007 | US7205403 Preferential G protein coupled receptor antagonists, such as 8-(3-amino-1-methyl-1H-pyrazol-5-yl)-1,3-dipropyl-3,7-dihydro -1H-purine-2,6-dione, used for prophylaxis of asthma, autoimmune diseases or retinopathy |
| 04/17/2007 | US7205386 Truncated CD200 |
| 04/17/2007 | US7205382 Solid phase synthesis; for autoimmune diseases, rheumatoid diseases, multiple sclerosis, and myasthenia gravis |
| 04/17/2007 | US7205327 Benzoimidazole or imidazole-2-carbonyl)-amino)-3-methyl butyrylamino)-5-fluoro-4-oxo- derivatives |
| 04/17/2007 | US7205324 IMPDH (inosine-5'-monophosphate dehydrogenase); transplant rejection and autoimmune diseases |
| 04/17/2007 | US7205308 Trisubstituted 7-aminopyrazolopyrimidines as cyclin dependent kinase inhibitors |
| 04/17/2007 | US7205306 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands |
| 04/17/2007 | US7205302 Anticoagulants; antilipemic agents; cardiovascular disorders |
| 04/17/2007 | US7205286 (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses |
| 04/17/2007 | US7205284 Potent immunostimulants from microalgae |
| 04/17/2007 | US7205274 Hybrid peptides modulate the immune response |
| 04/17/2007 | US7205151 Antiinflammatory agents; skin disorders |
| 04/17/2007 | US7205137 for enzyme resistance/gene overexpression; allow in vitro synthesis of homogenous N-glycans or glycoconjugates |
| 04/17/2007 | US7205119 HA-1 antigen |
| 04/17/2007 | US7205113 Regulation of T cell responses, T cell proliferation, and induction of T cell death |
| 04/17/2007 | CA2348725C Vitamin d analogues |
| 04/17/2007 | CA2211314C A process for preparing certain aza cyclohexapeptides |
| 04/17/2007 | CA2184175C Isolated, tyrosinase derived peptides and uses thereof |
| 04/17/2007 | CA2141589C Antiretroviral enantiomeric nucleotide analogs |
| 04/17/2007 | CA2124260C Tetrahydropyran derivatives |
| 04/12/2007 | WO2007041506A1 Purine formulations and methods for managing disorders |
| 04/12/2007 | WO2007041368A2 Dpp iv inhibitor for use in the treatment of autoimmune diseases and graft rejection |
| 04/12/2007 | WO2007040446A1 Use of lactobacillus for treatment of autoimmune diseases |
| 04/12/2007 | WO2007040231A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | WO2007040123A1 Method for detection of human precursor t cell and precursor b cell |
| 04/12/2007 | WO2007040105A1 Method for production of t cell population |
| 04/12/2007 | WO2007039451A1 Use of the neutrophil activating protein of helicobacter pylori (hp-nap) and/or of its portions as adjuvants for the development of t helper type 1 (th1) immune responses |
| 04/12/2007 | WO2007039297A1 Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 04/12/2007 | WO2007039216A1 Phenyl-(4-phenyl-pyrimidin-2-yl)-amines for enhancing immunotolerance |
| 04/12/2007 | WO2007039150A2 Cell populations having immunoregulatory activity, method for isolation and uses |
| 04/12/2007 | WO2007038876A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/12/2007 | WO2007017264A3 Pyrrolopyridinederivatives as modulators of the cannabinoid receptor for the treatment of immune and inflammatory disorders |
| 04/12/2007 | WO2007015002A3 Novel crystalline iv form of agomelatine, method of the preparation thereof and pharmaceutical compositions containing said form |
| 04/12/2007 | WO2006125921A3 Antibody or antibody fragment coupled with an immunogenic agent |
| 04/12/2007 | WO2006021458A3 Pyrimidine derivatives |
| 04/12/2007 | US20070082957 2-chloro-5-(3-oxopropyl)-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide; P2X7 receptor antagonists; inflammatory, immune or cardiovascular diseases |
| 04/12/2007 | US20070082912 Pyrrole compounds for the treatment of prostaglandine mediated diseases |
| 04/12/2007 | US20070082382 Development of human monoclonal antibodies and uses thereof |
| 04/12/2007 | US20070082369 Method for production and use of mite group 1 proteins |
| 04/12/2007 | US20070082362 Modified soluble t cell receptor |
| 04/12/2007 | US20070082341 Human phospholipases |
| 04/12/2007 | US20070082068 Il-8 production promoters and use thereof |
| 04/12/2007 | US20070082041 Topical delivery of codrugs |
| 04/12/2007 | US20070081991 Compositions and methods for modulation of immune responses |
| 04/12/2007 | US20070081990 Regulation of expression of high-affinity immunoglobulin e (ige) receptor beta-chain |
| 04/12/2007 | US20070081973 Cytokine polypeptides |
| 04/12/2007 | CA2625183A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 04/12/2007 | CA2624879A1 Imidazopyridine derivatives as a2b adenosine receptor antagonists |
| 04/12/2007 | CA2624660A1 Use of lactobacillus for treatment of autoimmune diseases |
| 04/12/2007 | CA2624141A1 Quinazoline derivative and pharmaceutical |
| 04/12/2007 | CA2623826A1 Dpp iv inhibitor for use in the treatment of autoimmune diseases and graft rejection |
| 04/12/2007 | CA2623735A1 Method for production of t cell population |
| 04/12/2007 | CA2623353A1 Cell populations having immunoregulatory activity, method for isolation and uses |
| 04/12/2007 | CA2621326A1 Conserved membrane activator of calcineurin (cmac), a novel therapeutic protein and target |
| 04/11/2007 | EP1772517A2 DSP-3 dual specificity phosphatase |
| 04/11/2007 | EP1772515A1 Immunoregulator from the family designated 'leukocyte immunoglobulin-like receptors' (LIR) |
| 04/11/2007 | EP1772464A2 Methods of identifying indirect agonists of IGF-1 |
| 04/11/2007 | EP1771571A2 Recombinant aav based vaccine methods |
| 04/11/2007 | EP1771469A1 Use of llt1 and/or cd161 for modulating the activity of cells of the immune system |
| 04/11/2007 | EP1771447A1 Fused pyrimidine derivatives and compositions thereof as cxcr3 receptor modulators, useful in prevention and treatment of inflammatory and immunoregulatory disorders and diseases |
| 04/11/2007 | EP1771425A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 04/11/2007 | EP1771178A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 04/11/2007 | EP1771155A2 Method and composition for treating rhinitis |
| 04/11/2007 | EP1511759A4 Modulators and inhibitors of fibroblast growth factor receptor 5-polypeptides and gene expression thereof. |
| 04/11/2007 | EP1435985B1 Medicament containing activated antithrombin iii |
| 04/11/2007 | EP1392641B1 Substituted cyclohexane-1,4-diamine derivatives |
| 04/11/2007 | EP1341767B1 Imidazole and benzimidazole caspase inhibitors and uses thereof |
| 04/11/2007 | EP1280416B1 Pet food composition for reducing inflammatory response in cats |
| 04/11/2007 | EP1207868B1 Pharmaceutical tramadol salts |
| 04/11/2007 | EP0988379B1 Ldl-receptor |
| 04/11/2007 | EP0755407B1 Pharmaceutical peptide formulations for treatment of dust mite allergy |
| 04/11/2007 | CN1946682A Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester |
| 04/11/2007 | CN1946393A Preventive and/or therapeutic agent for chronic sinusitis |
| 04/11/2007 | CN1944463A Fusion protein with alpha-interferon activity and its coded gene and use |
| 04/11/2007 | CN1944452A 2-phenoxy chromone heteroside compounds and its preparing method and use |
| 04/11/2007 | CN1944417A Five-membered-ring compound |
| 04/11/2007 | CN1943785A A suspension used for treatment of hepatic transplantation rejection |
| 04/11/2007 | CN1943781A Orally administered peptides to ameliorate atherosclerosis |
| 04/11/2007 | CN1943746A A Chinese traditional medicinal preparation for treatment of urticaria |
| 04/11/2007 | CN1943745A A Chinese traditional medicinal preparation for treatment of urticaria |
| 04/11/2007 | CN1943744A A Chinese traditional medicinal preparation for treatment of urticaria |
| 04/11/2007 | CN1943715A A Chinese traditional medicinal injection preparation and its preparation method |
| 04/11/2007 | CN1943699A A Chinese traditional medicinal preparation for treatment of eczema |
| 04/11/2007 | CN1943692A Regenesis of vita source |